Philippe Delahaut Selected Research

Philippe Delahaut Research Topics

3	Infections 01/2021 - 03/2007
3	Shellfish Poisoning 11/2014 - 12/2009
3	Diabetes Mellitus 01/2008 - 03/2006
2	COVID-19 01/2021 - 10/2020
2	Hypersensitivity (Allergy) 01/2021 - 10/2020
2	Serum Sickness 01/2021 - 10/2020
2	Protozoan Infections 07/2014 - 06/2011
1	Acromegaly 10/2023
1	Celiac Disease (Celiac Sprue) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Tetanus 01/2017
1	Pain (Aches) 01/2017
1	Rabies (Hydrophobia) 01/2017
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 03/2016
1	Weight Gain 02/2015
1	Obesity 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014
1	Coccidiosis 09/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2005

3	Insulin (Novolin)FDA Link 01/2008 - 03/2006
2	XAV-19IBA 01/2021 - 10/2020
2	AcidsIBA 01/2021 - 10/2020
2	AngiotensinsIBA 01/2021 - 10/2020
2	CarbohydratesIBA 01/2021 - 10/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 10/2020
2	AntibodiesIBA 10/2020 - 01/2017
2	domoic acidIBA 11/2014 - 10/2013
2	CoccidiostatsIBA 07/2014 - 09/2012
2	Insulin Glargine (Lantus)FDA Link 03/2007 - 06/2005
1	Human Growth Hormone (Saizen)FDA LinkGeneric 10/2023
1	Glutens (Glutelin)IBA 01/2021
1	Heterophile AntibodiesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2020
1	AntigensIBA 10/2020
1	EpitopesIBA 10/2020
1	Estrogens (Estrogen)FDA Link 01/2017
1	Snake Venoms (Snake Venom)IBA 01/2017
1	Immune Sera (Antisera)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	ThiouracilIBA 02/2015
1	SRT2104IBA 01/2014
1	Okadaic AcidIBA 10/2013
1	Veterinary Drugs (Veterinary Drug)IBA 09/2012
1	malachite greenIBA 06/2011
1	triphenylmethaneIBA 06/2011
1	Coloring Agents (Dyes)IBA 06/2011
1	EnzymesIBA 12/2009
1	ImmunosorbentsIBA 12/2009
1	Short-Acting InsulinIBA 01/2008
1	Therapeutic UsesIBA 01/2008
1	FluoroquinolonesIBA 03/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007
1	Insulin Aspart (NovoLog)FDA Link 06/2005
1	Insulin Lispro (Humalog)FDA Link 06/2005
1	InsulinsIBA 06/2005

1	Organ Transplantation 01/2017
1	Therapeutics 03/2006